Informazioni sul prodotto
- 4-methyl-N-[3-(5-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-
- 4-Methyl-N-[3-(5-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]benzamide
- 4-Methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-N-[5-(5-methyl-1H-imidazol-1-yl)-3-(trifluoromethyl)phenyl]benzamide
- 4-Methyl-N-[3-(5-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-[[4-(pyridin-3-yl)pyrimidin-2-yl]amino]benzamide
- Nilotinib isomer
Applications Nilotinib Regio Isomer is a more potent Bcr-Abl tyrosine kinase inhibitor for the treatment of patients with myelogenous leukemia. It is a COVID19-related research product.
References Wei-Sheng H., et al.: Synthesis, 14, 2121 (2007); Bilbe, G.,et al.: From PCT Int. Appl. (2005), WO 2005039586 A1 20050506
Proprietà chimiche
Richiesta tecnica su: TR-N465320 Nilotinib Regio Isomer
Se si desidera richiedere un preventivo o effettuare un ordine, si prega invece di aggiungere i prodotti desiderati al carrello e poi richiedere un preventivo o un ordine dal carrello. È più veloce, più economico, e potrà beneficiare degli sconti disponibili e di altri vantaggi.